Senior Business Development Manager, TIDES Development
Boost your chances before you apply.
WuXi AppTec
US
Summary
The role focuses on uncovering and cultivating business relationships to generate revenue for oligonucleotide and peptide CDMO services. Key duties include hunting for new leads, managing existing accounts, and representing the company at industry tradeshows.
Job Description
Overview
The incumbent will uncover and cultivate business relationships and opportunities to generate revenue with prospective and existing clients for WuXi TIDES and STA Pharmaceutical, a WuXi AppTec company, in particular to support the growth of emerging oligonucleotide and peptide (O&P) Contract Development and Manufacture (CDMO) business. The candidate will work within the US business development (BD) team to pursue new clinical to commercial company leads, manage existing clinical to commercial accounts, follow up on critical issues, and aid in resolving customer inquiries. This job is remote in the US.
Responsibilities
- Hunting and Prospecting for oligonucleotide and peptide new drug development contacts and companies that would benefit from WuXi TIDES CDMO services.
- Obtains conferences and meetings to present WuXi TIDES services to prospective and existing clients via email, phone, and web-conferencing systems. Travel to local client meetings where possible.
- Participates in tradeshows to raise the profile of WuXi TIDES and generate leads
- Acts upon, refers and follows-up on leads from both sales and marketing campaigns.
- Increase awareness of WuXi TIDES marketing initiatives, including scheduling meetings at tradeshows and promoting registrations for webinars and seminars.
- Maintains knowledge of industry trends, funding, regulatory influence, mergers and acquisitions, in-out licensing of products/technologies, government/private grants and contacts, new drug development and approvals, related patent grants and notifications, and market growth of small, med, and large cap companies.
- Develops a social network of industry-related contacts via LinkedIn and other social networking platforms.
- Proposes new ideas to increase performance for WuXi TIDES goals.
- Documents information in Client Relationship Management (CRM) including contacts, pre-screened/qualified leads, and new account information as required
Qualifications
- BA/BS in Chemistry and certain professional training/experience in business (i.e., Marketing, Sales) is required. PhD highly desired.
- 3+ year’s relevant experience working in oligonucleotide or peptide new drug development or CRO/CMO industry
- Must be a self-starter, self-motivated, highly flexible, with excellent communication skills (verbal, written, and presentation skills). Must be organized and detail-oriented.
- Must have a proven track record of simultaneously managing several projects and timelines.
- Ability to perform within a professional environment and use judgment as dictated by the complexity of the situation.
- Experience with CRM (Customer Relationship Management) software (i.e., Salesforce and/or Microsoft Dynamics/CRM) is preferred
An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status, and will not be discriminated against on the basis of disability.
This job description does not state or imply that the above are the only duties and responsibilities assigned to this position. Employees holding this position will be required to perform any other job-related duties as requested by Management.
Established in December 2000, WuXi AppTec (NYSE: WX) is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in China and the United States.
WuXi AppTec has successfully established a fully integrated services and technology platform during the past decade. The company built its initial capabilities around discovery chemistry and has further enhanced the integrated services with analytical services, bio-analytical services, process research, process development services, API manufacturing services, DMPK/ADME, discovery biology, pharmacology, formulation, toxicology, genomic services, biologics manufacturing services, antibody and biological research reagent manufacturing and sales, and most recently clinical research and regulatory services.
WuXi AppTec has developed from four founders and a single laboratory in December 2000 to 10,000 employees and 5 million square feet of laboratory and manufacturing space, including facilities under construction. The company is actively improving its capabilities and capacity through new expansions in its global business. Capitalizing on the great advantage of conducting R&D services both in China and in the U.S., WuXi AppTec is building an alternative R&D engine to serve the global life-science industry.
药明康德新药开发有限公司于2000年12月成立,是全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台公司,在中美两国均有运营实体。
十多年来,药明康德成功打造了全方位一体化的研发服务技术平台。创建之初,药明康德凭借其在发现化学合成领域的雄厚实力实现了全面发展。近几年来,我们又新增了一系列一体化服务,包括分析服务、生物分析服务、工艺研究、工艺研发服务、API生产服务、药物代谢及其动力学服务、研发生物学、药理学、制剂、毒理学、基因组服务、生物制剂生产服务、抗体及生物诊断试剂的生产和销售服务以及临床研发和产品注册服务等。
从 2000 年 12 月创立至今,药明康德的员工数从4 人增长至 10000 人,实验室由当初仅有的一间增长到近46 万平方米已有及在建研发基地和生产厂房。与此同时,药明康德还在不断增强服务能力,拓宽服务领域,以更好地服务公司持续增长的全球业务需求。作为一家全球领先的医药研发服务公司,药明康德将继续致力于在中美两国为全球客户提供高质量的医药研发服务,帮助研发出更多造福患者的新药及产品。
Company size
10,001+ employees
Industry
Pharmaceutical Manufacturing
Org type
Privately Held
Headquarters
Shanghai
Established in December 2000, WuXi AppTec (NYSE: WX) is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in China and the United States.
WuXi AppTec has successfully established a fully integrated services and technology platform during the past decade. The company built its initial capabilities around discovery chemistry and has further enhanced the integrated services with analytical services, bio-analytical services, process research, process development services, API manufacturing services, DMPK/ADME, discovery biology, pharmacology, formulation, toxicology, genomic services, biologics manufacturing services, antibody and biological research reagent manufacturing and sales, and most recently clinical research and regulatory services.
WuXi AppTec has developed from four founders and a single laboratory in December 2000 to 10,000 employees and 5 million square feet of laboratory and manufacturing space, including facilities under construction. The company is actively improving its capabilities and capacity through new expansions in its global business. Capitalizing on the great advantage of conducting R&D services both in China and in the U.S., WuXi AppTec is building an alternative R&D engine to serve the global life-science industry.
药明康德新药开发有限公司于2000年12月成立,是全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台公司,在中美两国均有运营实体。
十多年来,药明康德成功打造了全方位一体化的研发服务技术平台。创建之初,药明康德凭借其在发现化学合成领域的雄厚实力实现了全面发展。近几年来,我们又新增了一系列一体化服务,包括分析服务、生物分析服务、工艺研究、工艺研发服务、API生产服务、药物代谢及其动力学服务、研发生物学、药理学、制剂、毒理学、基因组服务、生物制剂生产服务、抗体及生物诊断试剂的生产和销售服务以及临床研发和产品注册服务等。
从 2000 年 12 月创立至今,药明康德的员工数从4 人增长至 10000 人,实验室由当初仅有的一间增长到近46 万平方米已有及在建研发基地和生产厂房。与此同时,药明康德还在不断增强服务能力,拓宽服务领域,以更好地服务公司持续增长的全球业务需求。作为一家全球领先的医药研发服务公司,药明康德将继续致力于在中美两国为全球客户提供高质量的医药研发服务,帮助研发出更多造福患者的新药及产品。
Company size
10,001+ employees
Industry
Pharmaceutical Manufacturing
Org type
Privately Held
Headquarters
Shanghai